Prelude Capital Management, LLC Synaptogenix, Inc. Transaction History

Prelude Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.6 - $172.25 $19,701 - $737,746	-4,283 Reduced 29.82%	10,081 $68,000
Q2 2022 Aug 15, 2022	BUY	$3.88 - $7.41 $6,790 - $12,967	1,750 Added 13.87%	14,364 $75,000
Q1 2022 May 16, 2022	SELL	$6.31 - $10.09 $33,379 - $53,376	-5,290 Reduced 29.55%	12,614 $98,000
Q4 2021 Feb 14, 2022	SELL	$8.38 - $13.72 $38,279 - $62,672	-4,568 Reduced 20.33%	17,904 $152,000
Q3 2021 Nov 15, 2021	BUY	$6.65 - $12.1 $58,606 - $106,637	8,813 Added 64.52%	22,472 $223,000
Q2 2021 Aug 16, 2021	BUY	$5.12 - $11.13 $69,934 - $152,024	13,659 New	13,659 $135,000

30K

Ticker SNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,840,630
Market Cap $21M
Description
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.